PARTHENOLIDE: SUGGESTED DRUG FOR COVID-19

被引：0
|
作者：
Nemati, M. [1 ]
Pouya, F. Danesh [1 ]
Asl, E. Roshni [1 ]
Rasmi, Y. [1 ,2 ]
机构：
[1] Urmia Univ Med Sci, Dept Biochem, Sch Med, Orumiyeh, Iran
[2] Urmia Univ Med Sci, Cellular & Mol Res Ctr, Orumiyeh, Iran
来源：
INFEKTSIYA I IMMUNITET | 2020年 / 10卷 / 04期
关键词：
Parthenolide; COVID-19; NF-kappa B; ACTIVATION; INHIBITORS;
D O I：
10.15789/2220-7619-PSD-1509
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the 2019 novel coronavirus (2019-nCoV) that causes acute respiratory distress syndrome (ARDS) which is the main reason for patients mortality. One of the effective treatments to reduce the effects of this virus is parthenolide (PN). Parthenolide is a sesquiterpene lactone found in medicinal plants. It can inhibit several pro-inflammatory signaling pathways, in particular the ATPase activity of NLRP3. Based on its ability to suppress inflammatory signal transduction and elevated level of serum IL-1 beta (a surrogate marker for NLRP3 activation) in COVID-19 patients, we suggest that PN could be potentiallyeffective for the treatment of COVID-19.
引用
收藏
页码：789 / 791
页数：3
相关论文
共 50 条
  • [31] Strategies suggested for emergency diagnosis and treatment of traumatic orthopedics in the epidemic of COVID-19
    Yang Yue
    Yu Aixi
    Xiao Wenxia
    Sun Zhibo
    Liu feng
    Wu Fei
    ChineseJournalofOrthopaedicTrauma, 2020, 22 (02) : 123 - 127
  • [32] Editorial: Drug Repurposing for COVID-19 Therapy
    Maldonado, Rafael
    Drago, Filippo
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [33] A review on drug repurposing applicable to COVID-19
    Dotolo, Serena
    Marabotti, Anna
    Facchiano, Angelo
    Tagliaferri, Roberto
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (02) : 726 - 741
  • [34] Drug repurposing approach to fight COVID-19
    Thakur Uttam Singh
    Subhashree Parida
    Madhu Cholenahalli Lingaraju
    Manickam Kesavan
    Dinesh Kumar
    Raj Kumar Singh
    Pharmacological Reports, 2020, 72 : 1479 - 1508
  • [35] Network analytics for drug repurposing in COVID-19
    Siminea, Nicoleta
    Popescu, Victor
    Martin, Jose Angel Sanchez
    Florea, Daniela
    Gavril, Georgiana
    Gheorghe, Ana-Maria
    Itcus, Corina
    Kanhaiya, Krishna
    Pacioglu, Octavian
    Popa, Laura Lona
    Trandafir, Romica
    Tusa, Maria Iris
    Sidoroff, Manuela
    Paun, Mihaela
    Czeizler, Eugen
    Paun, Andrei
    Petre, Ion
    BRIEFINGS IN BIOINFORMATICS, 2022, 23 (01)
  • [36] Chloroquine: A Potential Drug in the COVID-19 Scenario
    Ranjana Singh
    Viji Vijayan
    Transactions of the Indian National Academy of Engineering, 2020, 5 (2) : 399 - 410
  • [37] Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management
    Kelleni, Mina T.
    PHARMACOLOGICAL RESEARCH, 2020, 157
  • [38] COVID-19: ANALYSIS OF DRUG REPOSITIONING PRACTICE
    Savosina, P. I.
    Druzhilovskii, D. S.
    Poroikov, V. V.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2021, 54 (10) : 989 - 996
  • [39] Drug repurposing approach to fight COVID-19
    Singh, Thakur Uttam
    Parida, Subhashree
    Lingaraju, Madhu Cholenahalli
    Kesavan, Manickam
    Kumar, Dinesh
    Singh, Raj Kumar
    PHARMACOLOGICAL REPORTS, 2020, 72 (06) : 1479 - 1508
  • [40] POTENTIAL DRUG CANDIDATES FOR TREATMENT OF COVID-19
    Kumudhaveni, B.
    Kathirvel, S.
    Muthu, S. Deepak
    Jeradsuresh, A.
    Radha, R.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (09): : 4087 - 4094
12345